Pfizer
Pfizer launches iPhone service for doctors
June 3, 2010Medical Communications Apple, Epocrates, Pfizer, digital doctors, emedicine, iphone
A new service to allow doctors to communicate with Pfizer via iPhones and other mobile devices has been unveiled. Clinicians …
Inspra performs strongly in heart failure patients
May 28, 2010Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure
Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …
Pfizer R&D head exits for AstraZeneca
May 27, 2010Research and Development AstraZeneca, Pfizer, appointment, research and development
One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …
Pfizer takes the axe to manufacturing operations
May 19, 2010Manufacturing and Production Pfizer, job cuts, manufacturing
Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …
Pfizer signs ground-breaking academic research deal
May 18, 2010Research and Development Pfizer, US, academia, clinical research
Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …
Pfizer adds another product to its PAH franchise
May 14, 2010Research and Development Ergonex, PAH, Pfizer, Thelin, revatio, terguride, viagra
Pfizer has signed an agreement to acquire terguride, a drug for pulmonary arterial hypertension (PAH) currently in phase II testing, …
Pfizer to cut jobs in New York
May 11, 2010Sales and Marketing Pfizer, job cuts
Pfizer is reportedly planning to cut or relocate up to 1,400 jobs in New York in its on-going restructuring programme. …
Pfizer and Merck post modest results
May 6, 2010Sales and Marketing 2010 financials, Merck, Pfizer
The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine. Both …
Pfizer still at number 1, but Lipitor to slip
May 4, 2010Sales and Marketing Humira, Lipitor, Pfizer, sales
New research suggests that the pharma world is going to be shaken up over the next few years – although …
Pfizer first to disclose trial payments
April 1, 2010Research and Development, Sales and Marketing Pfizer, industry reputation, payments
Pfizer has disclosed in full the payments it has made to US doctors to conduct clinical trials and to promote …
Pfizer suffers late-stage cancer drug failures
March 12, 2010Research and Development Cancer, Pfizer, Sutent, figitumumab
Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …
Pfizer muscles in on Ratiopharm sale
March 11, 2010Sales and Marketing Pfizer, Ratiopharm, Teva, generics
Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …
Pfizer and King’s to collaborate on pain research
March 9, 2010Research and Development King's, Pfizer, UK
Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …
Digital Pharma: Byte-sized roundup
March 8, 2010Medical Communications Pfizer, digital pharma, digital pharma pfizer
A roundup of digital developments, including Pfizer’s new Facebook page and beta-phase science blog, Lundbeck, BMS, Baxter and Janssen-Cilag on …
Phase III success for apixaban
March 5, 2010Research and Development BMS, Pfizer, VTE, apixaban
Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
